Cure rate of 42% estimated in cure modeling; highest rate seen for patients with low Follicular Lymphoma International Prognostic Index scores.

Detailed price information for Citius Pharmaceuticals Inc (CTXR-Q) from The Globe and Mail including charting and trades.

The family of an “amazing” mother-of-two who died of an inoperable brain tumour is thanking the hospital which gave her access ...

New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...

In A Nutshell A new study found that nearly 72 percent of older adults with advanced cancer prioritized quality of life over survival, while only about 1 in 12 said living longer was their top ...

Detailed price information for Alx Oncology Holdings Inc (ALXO-Q) from The Globe and Mail including charting and trades.

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and ...

A meta-analysis of 13 studies showed that patients who underwent sentinel node biopsy had a significantly reduced risk of death from melanoma. In addition, an analysis of nine studies showed that the ...

Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...